ECM1 polypeptide epitopes bound to human MHC-class I molecules
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- ιζζ°
- Publication Date
- 2016-09-28
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of biomedical engineering, including screening and obtaining ECM1 polypeptide molecules combined with human major histocompatibility complex (MHC) class I molecules, as well as DNA and RNA encoding these polypeptides, because these polypeptides are compatible with human MHC-I Binding to the binding sites of the class of molecules can activate specific cytotoxic T lymphocytes (CTL cells), thereby effectively killing ECM1-positive tumor tissues and achieving the purpose of treating tumors. Background technique
[0002] Extracellular matrix protein-1 (ECM1) is a secreted glycoprotein isolated from the mouse osteogenic stromal cell line MN7 by Mathieu et al. in 1994. Its relative molecular mass is 85KD, and it has a hydrophobic signal peptide and several Glycosylation site. The gene is located on human chromosome 1q21 adjacent to the upper epidermal differentiation complex region, contains 11 exons, and is abou...